Monoclonal antibody 15A10
Alternative Names: Anti-cocaine monoclonal antibodyLatest Information Update: 09 Aug 2021
At a glance
- Originator Columbia University
- Class Monoclonal antibodies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cocaine-related disorders
Most Recent Events
- 19 Jun 2007 MedImmune has since been acquired by AstraZeneca
- 04 Oct 2004 Discontinued - Preclinical for Cocaine abuse in USA (unspecified route)
- 19 Oct 1999 Preclinical development for Cocaine abuse in USA (unspecified route)